(Q24243904)

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

Airway and systemic effects of hydrofluoroalkane fluticasone and beclomethasone in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

Improvement of asthma control with beclomethasone extrafine aerosol compared to fluticasone and budesonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

Comparison of the anti-inflammatory effects of extra-fine hydrofluoroalkane-beclomethasone vs fluticasone dry powder inhaler on exhaled inflammatory markers in childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

Hydrofluoroalkane-134A beclomethasone or chlorofluorocarbon fluticasone: effect on small airways in poorly controlled asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

Air trapping in mild and moderate asthma: effect of inhaled corticosteroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

Beclometasone dipropionate extrafine aerosol versus fluticasone propionate in children with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

Cough after inhalation of corticosteroids delivered from spacer devices in children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

Rapid effect of inhaled steroids on nocturnal worsening of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

Usefulness of HFA-BDP for adult patients with bronchial asthma: randomized crossover study with fluticasone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

Systemic effect comparisons of six inhaled corticosteroid preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

Effect of one year treatment with inhaled fluticasone propionate or beclomethasone dipropionate on bone density and bone metabolism: a randomised parallel group study in adult asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

Plasma concentrations of inhaled corticosteroids in relation to airflow obstruction in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

Hydrofluoroalkane-beclomethasone dipropionate effectively improves airway eosinophilic inflammation including the distal airways of patients with mild to moderate persistent asthma as compared with fluticasone propionate in a randomized open double-

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

Efficacy of beclomethasone dipropionate HFA 200 microg once daily in chronic obstructive pulmonary disease and bronchial asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

Comparison of patient preference and ease of teaching inhaler technique for Pulmicort Turbuhaler versus pressurized metered-dose inhalers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

Adrenal function and high dose inhaled corticosteroids for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

Budesonide for chronic asthma in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

Beclomethasone at different doses for chronic asthma (review).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

Beclomethasone versus placebo for chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

Fluticasone at different doses for chronic asthma in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

Fluticasone versus placebo for chronic asthma in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

True device compliance: the need to consider both competence and contrivance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering corticosteroids in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

Inhalation technique and variables associated with misuse of conventional metered-dose inhalers and newer dry powder inhalers in experienced adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

High dose versus low dose inhaled corticosteroid as initial starting dose for asthma in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

Beclomethasone for asthma in children: effects on linear growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

The efficacy and safety of QVAR (hydrofluoroalkane-beclometasone diproprionate extrafine aerosol) in asthma (part 1): an update of clinical experience in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

The efficacy and safety of QVAR (hydrofluoroalkane-beclometasone diproprionate extrafine aerosol) in asthma (Part 2): Clinical experience in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

Effect of inhaled corticosteroids on bone mineral density in childhood asthma: comparison of fluticasone propionate with beclomethasone dipropionate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

7 January 2021

Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. U.K. study group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

7 January 2021

Evaluation of fluticasone propionate (500 micrograms day-1) administered either as dry powder via a Diskhaler inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 micrograms day-1) administered by pressurized inhaler

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

7 January 2021

Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

7 January 2021

Hydrofluoroalkane-134a beclomethasone dipropionate, 400 microg, is as effective as chlorofluorocarbon beclomethasone dipropionate, 800 microg, for the treatment of moderate asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005309.PUB3

7 January 2021